MedImmune Inc

Activities: Manufacturing Research & Development Pharmaceutical

Trending Articles

  1. Lonza Capsules & Health Ingredients expands capsule manufacturing capacity in India and China New capsule manufacturing lines added at Lonza Capsules & Health Ingredients (CHI) facilities in Rewari (IN) and Suzhou (CN), highlighting the long-term strategic commitment to...
  2. You need to be a subscriber to read this article.
    Click here to find out more.
    How CDMOs can set a new gold standard when it comes to going green Sustainability is more than a feel-good initiative or a choice; it’s a strategic imperative. Not missing a beat, pharma companies have been making a concerted effort towards...
  3. Novo Holdings completes acquisition of Catalent Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark
  4. Resolving capping issues in tablet manufacturing Natoli explores the various causes of capping and the methods to prevent it
  5. You need to be a subscriber to read this article.
    Click here to find out more.
    Industrial data mastery: navigating the 2025 landscape As industrial manufacturers contend with the ever-increasing volume and variety of operational data, the year ahead promises both complexity and opportunity

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

Related Content

Media

Merck is set to lead pharmaceutical licensing deals in 2018

GlobalData, a specialist data and analytics company, expects that 2018 is likely to be Merck’s year in terms of research and development collaboration
Research & Development

MedImmune and Abpro enter into a collaborative agreement for a novel bispecific antibody

Agreement to result in new spin out company, AbMed, as subsidiary of Abpro
Research & Development

AstraZeneca launches integrated genomics approach to transform drug discovery and development

The initiative includes new collaborations with Human Longevity, the Wellcome Trust Sanger Institute and The Institute for Molecular Medicine
Research & Development

AstraZeneca and Moderna Therapeutics link up to develop immuno-oncology mRNA therapeutics

Extension to an mRNA agreement for cardiovascular, metabolic and renal diseases set up in 2013
Manufacturing

Wacker Biotech grants MedImmune licence to use Esetec technology to manufacture antibody fragment

To help improve productivity and simplify the purification process
Research & Development

AstraZeneca signs third cancer deal in seven days

MedImmune enters into cancer vaccine collaboration and license agreement with Inovio Pharmaceuticals
Research & Development

Medimmune partners with the University of Sheffield to innovate cell factory technology

Partnership will create tools that could increase the yield and predictability of engineered proteins such as bispecific antibodies to treat a range of diseases
Subscribe now